A recent medical report published in the journal Future Oncology discussed the association between heart health and cancer risk and treatment outcomes.
Past News ReleasesRSS
Toronto, ON (PRWEB) April 02, 2013
Bel Marra Health, who offers high-quality, specially formulated vitamins and nutritional supplements, is reporting on new research outlining how there is now considered to be a tie between heart health and cancer treatment outcomes.
As Bel Marra Health reports in its article (http://www.belmarrahealth.com/heart-health/heart-health-and-what-it-means-for-cancer/) cancer is considered as one of the most deadly diseases affecting people around the world. Cancer is strongly associated with specific lifestyles, as well as particular genetic mutations that may significantly increase cancer risk.
A recent medical report published in the journal Future Oncology discussed the association between heart health and cancer risk and treatment outcomes. For decades, heart health has been considered as a separate medical entity from cancer. However, the authors of the recent medical report has shown that maintaining good heart health may actually decrease the chances of developing cancer by producing essential proteins that prevent the abnormal cell division of cells in specific organs of the body.
For example, the cells of the heart, called cardiomyocytes, produce chemicals called cytokines when an initial damage to the heart occurs. It is possible to assess heart health on a regular basis to monitor the level of cytokines in an individual; a low cytokine level will indicate that no damages currently occur in the body. On the other hand, an individual with cellular or tissue damage in a specific organ will generally show a higher level of cytokines in the blood and this will suggest that the person requires medical treatment for a specific disease, including that of cancer.
As the Bel Marra Health article reads, the report also discussed that monitoring various chemicals produced by the heart during treatment of cancer patients allows them to measure the response of the patient to chemotherapeutic drugs. A high level of heart-specific biomarkers may indicate that the drug used in the treatment may be toxic to the patient’s heart or cardiotoxic. Using less toxic yet equally effective anti-cancer drugs should then be administered to the patient.
The information provided in the recent medical report is very useful for both physicians and patients because it allows us to understand that maintaining good heart health may also reduce cancer risk. Following a healthy lifestyle, including that of consuming sufficient amounts of fruits and vegetables and engaging in regular exercise, may be beneficial to cardiovascular health by allowing cardiomyocytes to effectively screen for cellular and tissue damages within the body.
For patients undergoing chemotherapeutic treatment, the heart is usually monitored by physicians to determine if the patient is well responding to the administered drugs without any adverse side effects.
(SOURCE: “Future Oncol” Altena R, van Veldhuisen DJ. Heart matters: Cardiovascular complications related to cancer treatment.. 2013 Feb;9(2):137-40. doi: 10.2217/fon.12.194)
Bel Marra Health is the maker of “Heart Rescue” a high-quality nutritional supplement designed for heart health in formulations designed to address this specific health concern. All ingredients are backed with scientific evidence. Every product is tested for safety, quality, and purity at every stage of the manufacturing process. Furthermore, Bel Marra Health products are produced only in Health Canada approved facilities, going that extra mile to ensure our health conscious customers are getting top quality products. For more information on Bel Marra Health visit http://www.belmarrahealth.com or call 1-866-531-0466.